$Cassava Sciences (SAVA.US)$ Every News Headline: Cassava Sc...
$Cassava Sciences(SAVA.US$ Every News Headline: Cassava Sciences Announces Positive Top-Line Clinical Results in Phase 2 Study Evaluating Simufilam in Alzheimer’s Disease.
47% patients improve. Simufilam was safe and well tolarated. This is good news and no other drug has this kind if safety, improvement. Any Alzheimer’s patient would truly benefit from this. Don’t let the shorts and manipulators fool you
47% patients improve. Simufilam was safe and well tolarated. This is good news and no other drug has this kind if safety, improvement. Any Alzheimer’s patient would truly benefit from this. Don’t let the shorts and manipulators fool you
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
101682201-dna : then why drop like shit
72997440 : Maybe this will help president B ?